Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Obsidian Therapeutics Inc. market cap is $741.29M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Obsidian Therapeutics Inc. 52 week high is $49.97 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Obsidian Therapeutics Inc. 52 week low is $9.60 as of November 22, 2026.
Obsidian Therapeutics Inc. stock price today is $12.00.
Obsidian Therapeutics Inc. stock price yesterday was $12.15.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Obsidian Therapeutics Inc.'s P/E ratio is 0.07.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Obsidian Therapeutics Inc. P/B ratio is 2.3123.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Obsidian Therapeutics Inc. 50-day moving average is $13.71.